A human egg being fertilised using IVF

Polygenic scores and PGT: a problematic pairing

We explore a new type of test hitting the headlines and ask whether it could ever be approved for UK clinics
Render of Covid-19 virus cells and DNA helices

Covid-19 update: ‘problem’ variants found

New research shows that certain gene variants could be drivers for life-threatening Covid-19 illness

Implementing genomics across the UK

We explore a new paper that sets out the UK’s genomics healthcare plan for the next three years

Personalised prescribing report: five things we learned

We share some key highlights from this week’s landmark pharmacogenomics report
Lists of genomic bases: A, T, G and C

Repeat after me: what are repeat expansion disorders?

We learn how repeating sequences in our DNA can impact on health and how genome sequencing can make a diagnostic difference

Genomics Beyond Health: a new report

We step away from the healthcare sector this week to look at the bigger genomics picture

Polygenic score pilot for heart disease begins

NHS launches innovative genomic testing project that could help revolutionise heart disease identification and prevention

Cancer vs the immune system

This week, we explore the ways cancer cells can evade our bodies’ defences and how we can fight back
Render of a DNA helix and Planet Earth

Flash forward: genomics in 2022

In our second end-of-year roundup, we look ahead to three areas of genomics likely to spark discussion in the coming year
Visualisation of a genome sequence as a tunnel

Looking back: genomics in 2021

As we approach the end of 2021, we look back on the key developments in genomics and their impact on healthcare and society

100,000 Genomes Project 2021 update: rare disease

How has rare disease diagnosis and treatment improved in light of data gathered from the 100,000 Genomes Project? Find out in the second part of our series…
Interpretation of genomic data surrounded by circular screens

100,000 Genomes Project 2021 update: cancer

In the first instalment of a two-part series, we look at how the 100,000 Genomes Project continues to impact cancer care